Neurobiological Competitors

NTII Stock  USD 0.0001  0.00  0.00%   
Analyzing Neurobiological Technologies competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Neurobiological Technologies to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Neurobiological Technologies Correlation with its peers.
For more detail on how to invest in Neurobiological Stock please use our How to Invest in Neurobiological Technologies guide.

Neurobiological Technologies vs ForU Holdings Correlation

No risk reduction

The correlation between Neurobiological Technologies and FORU is 1.0 (i.e., No risk reduction) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Neurobiological Technologies and FORU in the same portfolio, assuming nothing else is changed.
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
0.000.00010.00
Details
Intrinsic
Valuation
LowRealHigh
0.000.0000840.00
Details
Naive
Forecast
LowNextHigh
0.00010.00010.0001
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.00010.00010.0001
Details

Neurobiological Technologies Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Neurobiological Technologies and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Neurobiological and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Neurobiological Technologies does not affect the price movement of the other competitor.

High positive correlations

GBIMANTH
SYVCANTH
OVITANTH
PZRXQANTH
SNNAQANTH
RBSHANTH
  

High negative correlations

FORUCOTQF
COTQFRBSH
FORUCMRA
COTQFCMRA
RBSHCMRA
COTQFSNNAQ

Risk-Adjusted Indicators

There is a big difference between Neurobiological Stock performing well and Neurobiological Technologies Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Neurobiological Technologies' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
ANTH  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
GBIM  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
SYVC  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
OVIT  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
PZRXQ  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
SNNAQ  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
CMRA  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
RBSH  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
COTQF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
FORU  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 

Neurobiological Technologies Competitive Analysis

The better you understand Neurobiological Technologies competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Neurobiological Technologies' competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Neurobiological Technologies' competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
NTII ANTH GBIM SYVC OVIT PZRXQ SNNAQ RBSH FORU
 0.00 
 0.0001 
Neurobiological
 0.00 
 0.0001 
Anthera
 0.00 
 0.0001 
GlobeImmune
 0.00 
 0.0001 
Synovics
 0.00 
 0.0001 
OncoVista
 0.00 
 0.0001 
PhaseRx
 0.00 
 0.0001 
Sienna
 0.00 
 0.0001 
Rebus
 0.00 
 0.0001 
ForU
Market Volatility
(90 Days Market Risk)
Market Performance
(90 Days Performance)
Odds of Financial Distress
(Probability Of Bankruptcy)
Current Valuation
(Equity Enterprise Value)
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Current Ratio
Net Asset
Profit Margin
EBITDA
Operating Margin
Current Valuation
Price To Book
Retained Earnings
Current Asset
Beta
Number Of Employees
Shares Outstanding
Cash Flow From Operations
Total Debt
Return On Equity
Z Score
Number Of Shares Shorted
Book Value Per Share
Return On Asset
Current Liabilities
Total Asset
Short Ratio
Target Price
Debt To Equity
Shares Owned By Institutions
Market Capitalization
Price To Earning
Price To Earnings To Growth
Price To Sales
Net Income
Earnings Per Share
Shares Owned By Insiders
Revenue
Working Capital
Cash And Equivalents
Cash Per Share
Gross Profit
Rate Of Daily Change
Day Median Price
Day Typical Price

Neurobiological Technologies Competition Performance Charts

Five steps to successful analysis of Neurobiological Technologies Competition

Neurobiological Technologies' competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Neurobiological Technologies in relation to its competition. Neurobiological Technologies' competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Neurobiological Technologies in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Neurobiological Technologies' competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Neurobiological Technologies, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Neurobiological Technologies position

In addition to having Neurobiological Technologies in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Commodities Funds Thematic Idea Now

Commodities Funds
Commodities Funds Theme
Funds or Etfs investing in commodities such as oil, gold, corn, soy, and agricultural goods. The Commodities Funds theme has 42 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Commodities Funds Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Neurobiological Technologies offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Neurobiological Technologies' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Neurobiological Technologies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Neurobiological Technologies Stock:
Check out Neurobiological Technologies Correlation with its peers.
For more detail on how to invest in Neurobiological Stock please use our How to Invest in Neurobiological Technologies guide.
You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Is there potential for Biotechnology market expansion? Will Neurobiological introduce new products? Factors like these will boost the valuation of Neurobiological Technologies. Anticipated expansion of Neurobiological directly elevates investor willingness to pay premium valuations. Understanding fair value requires weighing current performance against future potential. All the valuation information about Neurobiological Technologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Neurobiological Technologies's market price often diverges from its book value, the accounting figure shown on Neurobiological's balance sheet. Smart investors calculate Neurobiological Technologies' intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Since Neurobiological Technologies' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Neurobiological Technologies' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Neurobiological Technologies should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Neurobiological Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.